Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2009 08:05 ET | Source: Marshall Edwards, Inc.

Marshall Edwards Licenses the Investigational Anti-Cancer Compound NV-128 From Novogen Limited

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - August 5, 2009) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) and Marshall Edwards, Inc. (NASDAQ: MSHL) have concluded a license agreement for...
December 01, 2008 08:10 ET | Source: NOVOGEN LIMITED

Novogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem Cells

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - December 1, 2008) - Pharmaceutical company Novogen Limited (NASDAQ: NVGN) (ASX: NRT) today announced that work performed in collaboration with a...
October 30, 2008 19:19 ET | Source: Novogen, Limited

Marshall Edwards' Phenoxodiol and Novogen's NV-128 Display Divergent Mechanisms of Action but Potent Synergistic Anti-Cancer Activity When Used in Combination

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - October 30, 2008) - Pre-clinical studies presented at the 9th International Conference on Membrane Redox Systems in Wellington New Zealand this...
April 15, 2008 17:25 ET | Source: Novogen, Limited

Novogen's NV-128 Is a Unique Inhibitor of mTOR Dephosphorylation Leading to Caspase Independent Death in Chemoresistant Cancer Cells

SAN DIEGO, CA--(Marketwire - April 15, 2008) - Pre-clinical studies reviewed during an oral presentation here today at the annual meeting of the American Association for Cancer Research demonstrate...
March 25, 2008 08:01 ET | Source: NOVOGEN LIMITED

Yale Researchers to Present Data at AACR Conference Indicating That Novogen Compound NV-128 Uses mTOR Pathway to Induce Cell Death in Chemo-Resistant Ovarian Cancer Cells

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - March 25, 2008) - An abstract for an oral presentation to be given at the Annual Meeting of the American Association for Cancer Research, April 12...
October 24, 2007 08:07 ET | Source: Novogen

Novogen NV-128 Induces Novel Mode of Cell Death in Cancer Cells

SAN FRANCISCO, CA--(Marketwire - October 24, 2007) - Laboratory studies presented late yesterday at the annual AACR/EORTC/NCI Molecular Targets and Cancer Therapeutics conference demonstrate that...